| Type | Title | Date Released | |
|---|---|---|---|
6-K | Alps Group Inc Announces Shareholder Approval for Share Consolidation, Share Capital Increase, and Adoption of Second Amended and Restated Memorandum and Articl | ||
6-K | Alps Group Inc. Announces Postponement of Extraordinary General Meeting and Updated Virtual Participation Details | ||
6-K | Alps Group Inc. Announces 2026 Extraordinary General Meeting for Share Consolidation and Capital Increase | ||
6-K | Alps Group Inc Reports Fiscal Year 2026 Financial Results and Business Update | ||
20-F | Form 20-F | ||
NT 20-F | Form NT 20-F | ||
6-K | Alps Group Inc Launches Patient-Derived Organoid (PDO) Program to Advance Precision Oncology in Southeast Asia | ||
6-K | Alps Group Inc Subsidiary MyGenome Receives MS ISO 15189:2022 Accreditation for Whole Genome Sequencing | ||
6-K | Alps Group Inc Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency | ||
3 | Lee Hee Hang (Reporting) | ||
6-K | Alps Group Appoints Former Ernst & Young Partner Hee H. Lee to Board of Directors | ||
3 | Poh Chit Laa (Reporting) |